EMPLOYMENT AGREEMENTEmployment Agreement • February 10th, 2004 • Maxim Pharmaceuticals Inc • Medicinal chemicals & botanical products • California
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into effective as of October 1, 2003, by and between Maxim Pharmaceuticals, Inc., (the “Company”), and Kurt R. Gehlsen, Ph.D. (“Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties,” and individually referred to as a “Party.”
EMPLOYMENT AGREEMENTEmployment Agreement • February 10th, 2004 • Maxim Pharmaceuticals Inc • Medicinal chemicals & botanical products • California
EMPLOYMENT AGREEMENT made as of the 17th day of November, 2003 between Maxim Pharmaceuticals, Inc. (“Company”) and Larry G. Stambaugh (“Executive”).
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • February 10th, 2004 • Maxim Pharmaceuticals Inc • Medicinal chemicals & botanical products • Delaware
THIS LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into as of November 19, 2003 (the “Effective Date”) by and among MAXIM PHARMACEUTICALS, INC., a Delaware corporation (“Maxim Pharmaceuticals”), having an address of 8899 University Center Lane, Suite 400, San Diego, California 92122, and CYTOVIA, INC., a Delaware corporation and wholly-owned subsidiary of Maxim Pharmaceuticals (“Cytovia”), having an address of 8899 University Center Lane, Suite 400, San Diego, California 92122 (Maxim Pharmaceuticals and Cytovia are hereinafter collectively referred to as “Maxim”), and MYRIAD GENETICS, INC., a Delaware corporation, having an address of 320 Wakara Way, Salt Lake City, Utah 84108 (“Myriad”).
